Allogene Therapeutics competitorsClear all

Allogene Therapeutics's top competitors include Novartis, Amgen, Bellicum Pharmaceuticals, Gilead Sciences, Cellectis and Legend Biotech.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T therapies for cancer.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Cellectis
Cellectis
Cellectis is a biopharmaceutical company focused on developing develop a new generation of cancer immunotherapies based on engineered allogeneic T-cells.
Legend Biotech
Legend Biotech
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
Founding Date
Founding Date
2018
Founding Date
1996
Founding Date
1980
Founding Date
2004
Founding Date
1987
Founding Date
1999
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Machelen, BE
Santo Amaro, BR
see more
Locations
Houston, US HQ
Houston, US
Houston, US
South San Francisco, US
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Paris, FR HQ
Lyon, FR
New York, US
Raleigh, US
Locations
Piscataway, US HQ
Nanjing, CN
Nanjing Shi, CN
Dublin, IE
Franklin Township, US
Franklin Township, US
Employees
Employees
2058% increase
Employees
110,0004% increase
Employees
24,200
Employees
10738% decrease
Employees
14,4006% increase
Employees
272
Employees
650
Valuation ($)
Valuation ($)
1 b
Valuation ($)
N/A
Valuation ($)
137.9 b
Valuation ($)
13.3 m
Valuation ($)
78.1 b
Valuation ($)
140.8 m
Valuation ($)
5.4 b
Twitter followers
Twitter followers
2 k
Twitter followers
299.8 k
Twitter followers
105.3 k
Twitter followers
580
Twitter followers
70.7 k
Twitter followers
4.5 k
Twitter followers
617
Number of tweets (last 30 days)
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
32
Number of tweets (last 30 days)
136
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
26
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
6
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
10.8
Average likes per tweet (last 30 days)
5.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
155.8
Average likes per tweet (last 30 days)
3.1
Average likes per tweet (last 30 days)
2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
37.5%
Percentage of tweets with engagement (last 30 days)
95.59%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
703432
Alexa Website Rank
102511
Alexa Website Rank
181163
Alexa Website Rank
211878
Alexa Website Rank
128868
Alexa Website Rank
324396
Alexa Website Rank
393967
Employee Rating
Employee Rating
4.4
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
2.7
Employee Rating
3.8
Employee Rating
2.9
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$52.9b (FY, 2021)
Revenue (est.)
$26b (FY, 2021)
Revenue (est.)
$500k (FY, 2020)
Revenue (est.)
$27.3b (FY, 2021)
Revenue (est.)
$73.9m (FY, 2020)
Revenue (est.)
$75.7m (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
($9.7b) (FY, 2021)
Cost of goods
$6.5b (FY, 2021)
Cost of goods
N/A
Cost of goods
$6.6b (FY, 2021)
Cost of goods
($39.7m) (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$45.1b (FY, 2021)
Gross profit
$19.5b (FY, 2021)
Gross profit
N/A
Gross profit
$20.7b (FY, 2021)
Gross profit
$42.7m (FY, 2020)
Gross profit
N/A
Net income
Net income
($250.2m) (FY, 2020)
Net income
$24b (FY, 2021)
Net income
$5.9b (FY, 2021)
Net income
($7.7m) (FY, 2020)
Net income
$6.2b (FY, 2021)
Net income
($97.5m) (FY, 2020)
Net income
($303.5m) (FY, 2020)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
100 (FY, 2020)
Countries
N/A
Countries
35 (FY, 2020)
Countries
N/A
Countries
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
N/A
Patents (US)
650 (Dec, 2020)
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
4 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
54 (FY, 2021)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
8 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
27 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
3 (FY, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A

Funding

Total funding raised
Total funding raised
$ 532m
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 3.2m
Total funding raised
$ 150.5m
For sources of this data, please see the company profile

View company profiles

Novartis
HQ
Basel, CH
Employees
110,000↑ 4% increase

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company
Amgen
HQ
Thousand Oaks, US
Employees
24,200

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company
Bellicum Pharmaceuticals
HQ
Houston, US
Employees
107↓ 38% decrease

Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.

View company
Gilead Sciences
HQ
Foster City, US
Employees
14,400↑ 6% increase

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.

View company